ABOUTREPATHA.COM

Last Updated: June 16, 2024

ABOUTREPATHA.COM Summary

aboutrepatha.com has 4 NS records, 2 A records, 0 AAAA records, 2 MX records, and 0 TXT records. Name servers for aboutrepatha.com are ns-605.awsdns-11.net, ns-74.awsdns-09.com, ns-1779.awsdns-30.co.uk, ns-1147.awsdns-15.org. A records for aboutrepatha.com are 52.33.115.127, 34.210.133.148. MX records that process @aboutrepatha.com email are mxb-0018ee02.gslb.pphosted.com, mxa-0018ee01.gslb.pphosted.com. We have observed aboutrepatha.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a Apache/2.4.33 (Unix) web server at 54.148.5.58 in United States. The website's description is: "learn about how repatha® helps to reduce your risk of another heart attack or stroke, and lower high bad cholesterol. see full safety & prescribing info."

Search DigitalStakeout ASI to find another asset.

ABOUTREPATHA.COM DNS Records

AAAA Records

No DNS AAAA records

TXT Records

No DNS TXT records

Search DigitalStakeout ASI to find another asset.

ABOUTREPATHA.COM Subdomains

aboutrepatha.com has 1 subdomains in our inventory.

Hostname IP Address
aboutrepatha.com 52.33.115.127

Search DigitalStakeout ASI to find another asset.

ABOUTREPATHA.COM Website

Web Server

Apache/2.4.33 (Unix)

IP Address

54.148.5.58

Country

United States

Meta Tags

og:description: learn about how repatha® helps to reduce your risk of another heart attack or stroke, and lower high bad cholesterol. see full safety & prescribing info.

og:type: website

og:image: https://www.repatha.com/-/media/themes/amgen/repatha-com-redesign/repatha-com-redesign/images/logos/repatha-logo.svg

og:title: high bad cholesterol (ldl-c) treatment | repatha® (evolocumab)

og:url: https://www.repatha.com

Search DigitalStakeout ASI to find another asset.

ABOUTREPATHA.COM Certificate Trust

No certificate log entry found for aboutrepatha.com. Please check back at a later time.

Search DigitalStakeout ASI to find another asset.